A multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of Siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with Multicentric Castleman's disease

被引:0
|
作者
Hess, G. [1 ]
Kirsch, A. [2 ]
Wong, R. S. [3 ]
Casper, C. [4 ]
Munshi, N. [5 ]
Fossa, A. [6 ]
Cavet, J. [7 ]
Bandekar, R. [8 ]
Rothman, M. [9 ]
Puchalski, T. A.
Chaturvedi, S.
van de Velde, H. [10 ]
Vermeulen, J. [11 ]
van Rhee, F. [12 ]
机构
[1] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 3, D-55122 Mainz, Germany
[2] Med Versorgungszentrum Onkol Schwerpunkt Oskar He, Berlin, Germany
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Norwegian Radium Hosp, Oslo, Norway
[7] Christie NHS Fdn Trust, Manchester, Lancs, England
[8] Janssen Res & Dev, Spring House, PA USA
[9] Janssen Res & Dev, Washington, DC USA
[10] Janssen Res & Dev, Beerse, Belgium
[11] Janssen Res & Dev, Leiden, Netherlands
[12] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P251
引用
收藏
页码:77 / 77
页数:1
相关论文
共 50 条
  • [41] The Efficacy and Safety of Lurasidone in Adolescent Patients With Schizophrenia: A 6-Week, Double-Blind, Placebo-Controlled, Multicenter Study
    Correll, Christoph U.
    Goldman, Robert
    Silva, Robert
    Cucchiaro, Josephine
    Deng, Ling
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S597 - S598
  • [42] Safety and tolerability of anti-IL-5 monoclonal antibody (Mepolizumab) therapy in patients with HES: A multicenter, randomized, double-blind, placebo-controlled trial.
    Klion, Amy D.
    Rothenberg, Marc E.
    Murray, John J.
    Singh, Anish
    Simon, Hans-Uwe
    BLOOD, 2006, 108 (11) : 762A - 762A
  • [43] Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease
    Blass, JP
    Cyrus, PA
    Bieber, F
    Gulanski, B
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 (01): : 39 - 45
  • [44] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [45] A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND TOLERANCE OF REGADENOSON IN PATIENTS WITH RENAL IMPAIRMENT
    Ananthasubramaniam, Karthikeyan
    Weiss, Robert
    Klauke, Barbara
    McNutt, Bruce
    Feaheny, Kathleen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E650 - E650
  • [46] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [47] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [48] Efficacy and Safety of the Cudrania tricuspidata Extract on Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Multicenter Study
    Shin, Jinyoung
    Oh, Tae-Hoon
    Kim, Joo-Yun
    Shim, Jae-Jung
    Lee, Jung-Lyoul
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [49] EFFICACY AND SAFETY OF LUBIPROSTONE IN CHILDREN WITH FUNCTIONAL CONSTIPATION: A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND PIVOTAL STUDY
    Benninga, Marc A.
    Hussain, Sunny Z.
    Sood, Manu R.
    Nurko, Samuel
    Hyman, Paul E.
    Losch-Beridon, Taryn
    Lichtlen, Peter
    Di Lorenzo, Carlo
    GASTROENTEROLOGY, 2018, 154 (06) : S559 - S560
  • [50] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, JY
    Cho, KH
    Oho, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Choi, KD
    Cho, HS
    Lee, HT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2